All Stories

  1. Efficacy of a Clinical Prediction Rule to Identify Febrile Young Infants at Low Risk for Serious Bacterial Infections
  2. The Clinical Utility of Respiratory Viral Testing in Hospitalized Children: A Meta-analysis
  3. Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
  4. Inappropriate Antibiotic Prescribing for Acute Bronchiolitis in US Emergency Departments, 2007–2015
  5. Molecular and epidemiologic investigation of a rhinovirus outbreak in a neonatal intensive care unit
  6. Use of C-reactive protein to tailor antibiotic use: a systematic review and meta-analysis
  7. Use of Radiography in Patients Diagnosed as Having Acute Bronchiolitis in US Emergency Departments, 2007-2015
  8. Rapid and simple molecular tests for the detection of respiratory syncytial virus: a review
  9. Pediatric Investigators Collaborative Network on Infections in Canada Study of Respiratory Syncytial Virus–associated Deaths in Pediatric Patients in Canada, 2003–2013
  10. Can biomarkers improve the rational use of antibiotics?
  11. Procalcitonin and antibiotic use: imperfect, yet effective
  12. Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
  13. Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction
  14. Diagnostic yield and clinical impact of routine cell culture for respiratory viruses among children with a negative multiplex RT-PCR result
  15. Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasons
  16. Determinants of Antibiotic Tailoring in Pediatric Intensive Care
  17. Multiplex Respiratory Virus Testing for Antimicrobial Stewardship: A Prospective Assessment of Antimicrobial Use and Clinical Outcomes Among Hospitalized Adults
  18. Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosis
  19. Assessment of Surgical Antibiotic Prophylaxis in Pediatrics (ASAP-P)
  20. Palivizumab Adherence and Outcomes in Canadian Aboriginal Children
  21. Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings
  22. Factors Associated With Antibiotic Exposure in Children Less Than 3 Years Old Hospitalized With Bronchiolitis
  23. The accuracy and timeliness of neuraminidase inhibitor dispensing data for predicting laboratory-confirmed influenza
  24. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis
  25. Advances in Rapid Testing for Bacterial, Viral, and Parasitic Infections
  26. A Nine-Week-Old Girl with Fever and Seizures
  27. Human metapneumovirus viral load is an important risk factor for disease severity in young children
  28. Absence of Pleocytosis Alone Is Insufficient To Exclude Encephalitis Caused by Herpes Simplex Virus in Children
  29. Genetic diversity and molecular evolution of the major human metapneumovirus surface glycoproteins over a decade
  30. Host and Viral Factors Affecting Clinical Performance of a Rapid Diagnostic Test for Respiratory Syncytial Virus in Hospitalized Children
  31. Rapid antigen-based testing for respiratory syncytial virus: moving diagnostics from bench to bedside?
  32. Presence of Oseltamivir-Resistant Pandemic A/H1N1 Minor Variants Before Drug Therapy With Subsequent Selection and Transmission
  33. Seroconversion to Seasonal Influenza Viruses after A(H1N1)pdm09 Virus Infection, Quebec, Canada
  34. Comparison of Risk Factors for Human Metapneumovirus and Respiratory Syncytial Virus Disease Severity in Young Children
  35. Case 2: A neonate in shock
  36. Molecular Evolution of Respiratory Syncytial Virus Fusion Gene, Canada, 2006–2010
  37. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009–2011
  38. Comparison of Pandemic and Seasonal Influenza in the Pediatric Emergency Department
  39. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada
  40. Evaluation of Serological Diagnostic Methods for the 2009 Pandemic Influenza A (H1N1) Virus
  41. Household Transmission of the 2009 Pandemic A/H1N1 Influenza Virus: Elevated Laboratory‐Confirmed Secondary Attack Rates and Evidence of Asymptomatic Infections
  42. The distinguishing features of human metapneumovirus and respiratory syncytial virus
  43. Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
  44. What is the Significance of a High Cycle Threshold Positive IS481 PCR for Bordetella pertussis?
  45. Panton-Valentine leukocidin in pediatric community-acquired Staphylococcus aureus infections
  46. P54 High level of tigecycline susceptibility of Gram-negative rods from clinical isolates in a Canadian Institution: 2006–2008
  47. A Near-Fatal Infection with Oseltamivir-Resistant Seasonal Influenza A in a Previously Healthy Child: Case Report
  48. Community-Acquired Needle-Stick Injuries: Rapid and Safe Retrieval of Discarded Needles Is Essential: In Reply
  49. Pediatric Injuries From Needles Discarded in the Community: Epidemiology and Risk of Seroconversion
  50. Antiviraux